Design and Synthesis of Inhibitors of Folate Dependent Enzymes as Antitumor Agents

  • Edward C. Taylor
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 338)


Tetrahydrofolate coenzymes play critical roles in a host of cellular one-carbon transfer reactions. Among these are the de novo biosynthesis of both purine and pyrimidine nucleotides (and thus both ATP and DNA), the methylation of homocysteine to methionine, the interconversion of serine and glycine, and the catabolism of certain amino acids. Dihydrofolate reductase (DHFR) plays a central role in the majority of these metabolic reactions, for it is required for the regeneration of tetrahydrofolate from dihydrofolate, and thus is responsible for maintaining a constant cellular supply of this critical coenzyme. 1 Inhibitors of DHFR thus have the potential to be potent antiproliferative agents, since they interfere with many cellular processes critical for cell growth. The deleterious consequences with respect to normal cells are certainly responsible in part for the extreme toxicity of DHFR inhibitors such as methotrexate, and severely limit their clinical usefulness in cancer chemotherapy.2–6


Pyrimidine Ring Palladium Acetate Propargyl Alcohol Triethyl Orthoformate Pyridinium Chlorochromate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    R. L. Blakley, “The Biochemistry of Folic Acid and Related Pteridines,” North-Holland Publishing Co., Amsterdam (1969).Google Scholar
  2. 2.
    F. M. Sirotnak, J. J. Burchall, W. B. Ensminger, and J. A. Montgomery, eds., “Folate Antagonists as Therapeutic Agents, Vols. 1 and 2,” Academic Press, New York (1984).Google Scholar
  3. 3.
    F. M. Sirotnak, Prog. Cancer Res. Ther. 28:77 (1984).Google Scholar
  4. 4.
    D. W. Fry and R. C. Jackson, Cancer Metastasis Rev. 5:251 (1987).PubMedCrossRefGoogle Scholar
  5. 5.
    J. I. DeGraw, P. H. Christie, W. T. Colwell, and F. M. Sirotnak, J. Med. Chem. 35:320 (1992).PubMedCrossRefGoogle Scholar
  6. 6.
    For extensive reviews of the chemistry of folic acid, aminopterin, methotrexate and analogs as antitumor agents, seeGoogle Scholar
  7. 6(a).
    D. C. Palmer, J. S. Skoticki, and E. C. Taylor, “Progress in Medicinal Chemistry,” G. P. Ellis and G. B. West, Eds; Elsevier Science Publishers; Holland (1988); Vol. 25, p. 85.Google Scholar
  8. 6(b).
    Rosowsky, A. “Progress in Medicinal Chemistry,” G. P. Ellis and G. B. West, Eds; Elsevier Science Publishers; Holland (1989); Vol.26, 1Google Scholar
  9. 7.
    For leading references and a full discussion of the background and development of DDATHF, see E. C. Taylor, J. Heterocyclic Chem. 27:1 (1990).CrossRefGoogle Scholar
  10. 8.
    R. G. Moran, E. C. Taylor, and G. P. Beardsley, Proc. Amer. Assoc. Cancer Res. 26:231 (1985).Google Scholar
  11. 9.
    G. P. Beardsley, E. C. Taylor, C. Shih, G. A. Poore, G. B. Grindey, and R. G. Moran, Proc. Amer. Assoc. Cancer Res. 27:259 (1986).Google Scholar
  12. 10.
    G. P. Beardsley, B. A. Moroson, E. C. Taylor, and R. G. Moran, J. Biol. Chem. 264:328 (1989).PubMedGoogle Scholar
  13. 11.
    S. W. Baldwin, A. Tse, L. S. Gossett, E. C. Taylor, A. Rosowsky, C. Shih, and R. G. Moran, Biochemistry 30:1997 (1991).PubMedCrossRefGoogle Scholar
  14. 12.
    R. G. Moran, S. W. Baldwin, E. C. Taylor, and C. Shih, J. Biol. Chem. 264:21047 (1989).PubMedGoogle Scholar
  15. 13.
    G. Pizzorno, B. A. Moroson, A. R. Cashmore, E. C. Taylor, and G. P. Beardsley, Proc. Amer. Assoc. Cancer Res. 29:281 (1988).Google Scholar
  16. 14.(a)
    C. Young, V. Currie, L. Baltler, B. Trochanowski, O. Eton, R. Dyke, and R. Bowsher, Proc. Amer. Assoc. Cancer Res. 31:177 (1990).Google Scholar
  17. 14(b).
    R. Nelson, F. Butler, W. Dugan, Jr., C. Davis-lung, M. Stone, and R. Dyke, Proc. Amer. Soc. Clin. Oncol. 9:293 (1990).Google Scholar
  18. 14(c).
    O. Pagani, C. Sessa, J. deJong, H. Kern, S. Hatty, H. Schmitt, and F. Cavalli, Proc. Amer. Assoc. Clin. Oncol. 11:109 (1992).Google Scholar
  19. 15.
    E. C. Taylor, P. J. Harrington, S. R. Fletcher, G. P. Bearsley, and R. G. Moran, J. Med. Chem. 28:914 (1985).PubMedCrossRefGoogle Scholar
  20. 16.
    E. C. Taylor and G. S. K. Wong, J. Org. Chem. 54:3618 (1989).CrossRefGoogle Scholar
  21. 17.
    R. F. Heck, “Palladium Reagents in Organic Syntheses,” Academic Press, Orlando, FL(1985).Google Scholar
  22. 18.(a)
    E. C. Taylor and C.-m. Yoon, Synth. Commun. 18:1187 (1988).CrossRefGoogle Scholar
  23. 18(b).
    E. C. Taylor and P. S. Ray, J. Org. Chem. 52: 3997 (1987).CrossRefGoogle Scholar
  24. 18(c).
    E. C. Taylor, J. M. Hamby, C. Shih, G. B. Grindey, S. M. Rinzel, G. P. Beardsley, and R. G. Moran, J. Med. Chem. 32:1517 (1989).PubMedCrossRefGoogle Scholar
  25. 19.
    C.-m. Yoon, Ph.D. Thesis, Princeton University (1989).Google Scholar
  26. 20.
    E. C. Taylor, G. S. K. Wong, S. R. Fletcher, P. J. Harrington, G. P. Beardsley, and C. J. Shih, “Chemistry and Biology of Pteridines,” B. A. Cooper and V. M. Whitehead, Eds.; de Gruyter, Berlin (1986), pp. 61–64.Google Scholar
  27. 21.
    E. C. Taylor and P. M. Harrington, J. Org. Chem. 55:3222 (1990).CrossRefGoogle Scholar
  28. 22.
    A. I. Meyers, Acc. Chem. Res. 11:375 (1978).CrossRefGoogle Scholar
  29. 23.
    C. Shih, G. B. Grindey, E. C. Taylor, and P. M. Harrington, Biorg. Med. Chem. Lett. 2:339(1992).CrossRefGoogle Scholar
  30. 24.
    This separation, the first of its kind in folate chemistry, was developed by Dr. C. J. Shih of Eli Lilly & Company; see ref. 1.Google Scholar
  31. 25.
    E. C. Taylor, P. M. Harrington, and C. Shih, Heterocycles 28:1169 (1989).CrossRefGoogle Scholar
  32. 26.
    C. Shih, L. S. Gossett, J. F. Worzalla, S. M. Rinzel, G. B. Grindey, P. M. Harrington, and E. C. Taylor, J.Med. Chem. 35:1109 (1992).PubMedCrossRefGoogle Scholar
  33. 27.
    E. C. Taylor, T. H. Schrader, and L. D. Walensky, Tetrahedron 48:19 (1992).CrossRefGoogle Scholar
  34. 28.(a)
    E. C. Bigham, S. J. Hodson, W. R. Mallory, D. Wilson, D. S. Duch, G. K. Smith, and R. Ferone, J. Med. Chem. 35:1399 (1992).PubMedCrossRefGoogle Scholar
  35. 28(b).
    J. L. Kelley, E. W. McLean, N. K. Cohn, M. P. Edelstein, D. S. Duch, G. K. Smith, M. H. Hanlon, and R. Ferone, J. Med. Chem. 33:561 (1990).PubMedCrossRefGoogle Scholar
  36. 28(c).
    G. K. Smith, S. D. Banks, E. C. Bigham, N. K. Cohn, D. S. Duch, M. P. Edelstein, R. Ferone, M. H. Hanlon, L. S. Heath, J. Humphreys, J. L. Kelley, V. Knick, E. W. McLean, R. J. Mullin, S. Singer, H. R. Wilson, and J. Houghton,”Chemistry and Biology of Pteridines, 1989,” H.-Ch. Curtius, S. Ghisla, and N. Blau, Eds.; de Gruyter, Berlin (1990), pp. 1015–1022.Google Scholar
  37. 29.
    E. C.Taylor,P. Gillespie, and M. Patel, J. Org. Chem. 57:3218 (1992).CrossRefGoogle Scholar
  38. 30.
    C. Shih, G. B. Grindey, P. J. Houghton, and J. A. Houghton, Proc. Amer. Assoc. Cancer Res. 29:283 (1988).Google Scholar
  39. 31.
    E. C. Taylor, D. Kuhnt, and Z.-y. Chang, J. Org. Chem. 56:6937 (1991).CrossRefGoogle Scholar
  40. 32.
    E. C. Taylor, D. Kuhnt, C. Shih, S. M. Rinzel, G. B. Grindey, J. Barredo, M. Jannatipour, and R. G. Moran, J. Med. Chem. 35:4450 (1992).PubMedCrossRefGoogle Scholar
  41. 33.(a)
    J. Davoll, J. Chem. Soc. 131 (1960).Google Scholar
  42. 33(b).
    U. Lüpke, and F. Seela, Chem. Ber. 110:1462(1977).CrossRefGoogle Scholar
  43. 34.
    E. C. Taylor, and A. McKillop, “The Chemistry of Cyclic Enaminonitriles and o-Aminonitriles,” Wiley-Interscience, New York (1970).Google Scholar
  44. 35.
    C. J. Barnett, T. M. Wilson and G. B. Grindey, “Synthesis and Antitumor Activity of LY288601, the 5,6-Dihydro Analog of LY231514”, Poster presented at the 10th International Symposium, Chemistry and Biology of Pteridines and Folates, Orange Beach, Alabama, March 21–26, 1993. These workers prepared the 5,6-dihydro derivative of LY231514 by a different route .Google Scholar
  45. 36.
    T. Miwa, T. Hitaka, H. Akimoto and H. Nomura, J. Med. Chem. 34:555 (1991).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Edward C. Taylor
    • 1
  1. 1.Department of ChemistryPrinceton UniversityPrincetonUSA

Personalised recommendations